吸水性樹脂組成物、吸収体、及び吸収性物品

    公开(公告)号:WO2023074859A1

    公开(公告)日:2023-05-04

    申请号:PCT/JP2022/040440

    申请日:2022-10-28

    发明人: 山本 朋依

    摘要: 吸水性樹脂粒子と活性炭とを含む吸水性樹脂組成物であって、優れた消臭効果を有する、吸水性樹脂組成物を提供する。 吸水性樹脂粒子と、前記吸水性樹脂粒子の表面に配された活性炭とを含む、吸水性樹脂組成物であって、 前記吸水性樹脂組成物は、300mLの断熱容器内で、24.9℃の生理食塩水50gを600rpmで攪拌しつつ、吸水性樹脂組成物10gを投入して膨潤させた際、温度が2℃上昇する際の発熱速度が、0.10℃/秒以上1.00℃/秒以下である、吸水性樹脂組成物。

    VACUUM SEALED BANDAGE AND METHODS OF USE
    4.
    发明申请

    公开(公告)号:WO2022245337A1

    公开(公告)日:2022-11-24

    申请号:PCT/US2021/032883

    申请日:2021-05-18

    申请人: GOLLER, Stacey

    发明人: GOLLER, Stacey

    摘要: The present disclosure relates to wound bandages. More specifically, the present disclosure describes a vacuum sealed bandage having a film layer that is manipulable into a wound by way of negative pressure imparted by a removable medical syringe. The vacuum sealed bandage of the present disclosure does not have a vacuum pump, does not constantly apply negative pressure to the wound through an electro-mechanical device or vacuum pump, and/or does not have chords or tubes positioned to opposite sides of the film layer or extending from one side of the film layer to another side of a film layer where the chord or tube is positioned between the film and the wound.

    一种可拉伸纳米纤维膜及其制备方法和应用

    公开(公告)号:WO2022161505A1

    公开(公告)日:2022-08-04

    申请号:PCT/CN2022/075825

    申请日:2022-02-10

    发明人: 徐建林 刘瑞宁

    摘要: 本申请涉及医用纳米纤维材料制备的技术领域,具体公开一种可拉伸纳米纤维膜及其制备方法和应用。所述可拉伸纳米纤维膜具有芯壳结构,芯层包括氨基化壳聚糖载体和抗菌药物,所述抗菌药物掺杂在所述氨基化壳聚糖载体中;壳层包括聚氨酯载体、聚N-异丙基丙烯酰胺和N-TiO 2/活性炭,所述聚N-异丙基丙烯酰胺和所述N-TiO 2/活性炭掺杂在所述聚氨酯载体中。可拉伸纳米纤维膜通过同轴静电纺丝技术制备得到。本申请制备的纳米纤维膜具有拉伸性能优异、吸附性能强、抑菌时间长和自清洁的优势,可显著提高创口表面的愈合效果,在医用敷料领域具有广阔的应用前景。

    SELF-STERILIZING WOUND DRESSING
    8.
    发明申请

    公开(公告)号:WO2021212154A1

    公开(公告)日:2021-10-21

    申请号:PCT/US2021/070414

    申请日:2021-04-19

    IPC分类号: A61L15/26 A61L15/42 A61L15/44

    摘要: A self-sterilizing wound dressing is disclosed. The wound dressing comprises a substrate having a first surface facing at least a portion of a wound or a surgical site and a second surface facing opposite to the first surface. At least one surface of the substrate comprises a sulfonated polymer selected from the group of perfluorosulfonic acid polymers, polystyrene sulfonates, sulfonated block copolymers, sulfonated polyolefins, sulfonated polyimides, sulfonated polyamides, sulfonated polyesters, sulfonated polysulfones, sulfonated polyketones, sulfonated poly(arylene ether), and mixtures thereof. The sulfonated polymer is sufficiently or selectively sulfonated to contain from 10 - 100 mol % sulfonic acid or sulfonate salt functional groups based on the number of monomer units, for killing at least 90% of microbes in less than 120 minutes of coming into contact with the wound dressing.